lexiara

3.

Each year, the Executive Director shall submit to the Management Board for approval, while making a distinction between the Agency's activities concerning medicinal products for human use and those concerning veterinary medicinal products: a draft report covering the activities of the Agency in the previous year, including information about the number of applications evaluated within the Agency, the time taken for the completion of the evaluation and the medicinal products authorized, rejected or withdrawn, a draft programme of work for the coming year, the draft annual accounts for the previous year, the draft budget for the coming year.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.